Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma
about
Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementNew molecular insights into peripheral T cell lymphomasGenetic markers associated with progression in early mycosis fungoides.IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indicationsDistinct age-matched serum biomarker profiles in patients with cutaneous T-cell lymphoma.Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosisEvolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphomaEctopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphomaResimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma.Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registriesThe Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients.Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registriesAnalysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell linesCutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.Ectopic expression of cancer-testis antigens in cutaneous T-cell lymphoma patients.Elucidating the role of interleukin-17F in cutaneous T-cell lymphomaThe role of AHI1 and CDKN1C in cutaneous T-cell lymphoma progressionCutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.Cutaneous T-cell lymphomas: a review of new discoveries and treatments.Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?A three-signal model of T-cell lymphoma pathogenesisThe discovery and development of romidepsin for the treatment of T-cell lymphoma.Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.Vascular endothelial growth factor receptor-3 expression in mycosis fungoides.CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis.Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators.TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform.Connecting the dots in cutaneous T cell lymphoma (CTCL): STAT5 regulates malignant T cell proliferation via miR-155.Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines.Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010.Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndrome.Loss of BCL7A expression correlates with poor disease prognosis in patients with early-stage cutaneous T-cell lymphoma.
P2860
Q27024076-0923F115-8A07-4EE1-A1BC-DAA5563906C7Q27026081-6F3539DC-19DA-4D94-BCE6-FC7769C18725Q33556038-690417D3-F930-472E-9219-F145A71213E0Q33728396-B777B8F1-9051-42DD-9A9C-3926A59B16DBQ33746059-AAE80307-3AE3-40B6-8CDF-FF8D2307692AQ34017170-2BBB7C91-A9CF-4D32-A550-E2EFDF37EF38Q34100988-48ED3BF7-FE20-41ED-863E-F352919EA70BQ35022833-770933A7-2362-4B4E-8EDE-ECD42A212D9FQ35186682-0CE9259D-2925-4F4F-8F1F-E90AEFD252C7Q35201911-166711AB-D93D-458B-BE51-64343CBBB760Q35669880-EAADAEC5-D8AA-4BA0-8672-7CC42B489DFFQ35689166-8E413326-2593-456E-BE7D-A3AE8DF4A65CQ35752062-299A7C23-F793-4074-AB3F-061AA398F47BQ35987358-82DF1716-F879-4348-83D0-82871C0605E7Q36020985-842FE038-8223-43A9-8BC9-3461A101A91CQ36051812-E91E0CDC-BB52-435E-A333-AEE1DA40B3FBQ36187589-551EEB9A-90BB-4979-B59E-A6E153B540CDQ36470196-21D7FBCD-13B9-4404-A153-2534E33C3350Q36890779-2694A3DD-1348-4DFD-9721-40ED9FC60887Q37216178-5D8CA036-5BA1-4154-B241-03CBB6BEEEDCQ37561159-27140B01-AB18-489B-B613-DD80AD2177DCQ37944565-FD210CFF-B1EA-4C7A-AA96-005FF3DCB66CQ37981969-19439A4D-AE1E-405C-87C9-9107FF5C6FF0Q38196931-456F501E-C2E2-4AAA-BFB9-FBF4B9537C52Q38593164-4A965DC2-5C59-451D-A914-413674F12626Q38713744-EEE8029B-AE4D-4DA4-B2A4-F27498C196EAQ38792428-644C7F95-8439-4BA2-9A7C-3D4A74DF3B98Q39285766-B14790FE-3F55-47A2-8E86-F4C6EECD713BQ39549018-2839B813-6C24-4DBA-B577-687EE20F5BF0Q40150337-74D657BC-D3AC-4BBC-BD4F-DF18F23E454BQ42270898-47689CAF-8D66-485F-9872-395A84F90586Q42574067-5189150D-5B25-4CA0-963A-690D3CFA9758Q47100819-649FD5EB-1FE4-45A4-8E99-9D7719D80B2CQ47309417-1250A205-2102-400D-B6A9-2D7681940A88Q47818116-D47A7E9D-DDFF-4A6B-B523-30EAD2062E95Q55056532-0BDB979D-6C31-4C53-BF3C-5841867B4849
P2860
Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Transcriptional profiles predi ...... with cutaneous T-cell lymphoma
@ast
Transcriptional profiles predi ...... with cutaneous T-cell lymphoma
@en
type
label
Transcriptional profiles predi ...... with cutaneous T-cell lymphoma
@ast
Transcriptional profiles predi ...... with cutaneous T-cell lymphoma
@en
prefLabel
Transcriptional profiles predi ...... with cutaneous T-cell lymphoma
@ast
Transcriptional profiles predi ...... with cutaneous T-cell lymphoma
@en
P2093
P2860
P1476
Transcriptional profiles predi ...... with cutaneous T-cell lymphoma
@en
P2093
David A Jones
Denis Sasseville
Ivan V Litvinov
Thomas S Kupper
P2860
P304
P356
10.1158/1078-0432.CCR-09-2879
P407
P577
2010-03-16T00:00:00Z